Buyer's Guide
A research-based guide to the vitamins and supplements sold for tinnitus: what the only controlled trial of Lipo-Flavonoid found, what Cochrane reviews say about ginkgo and zinc, where melatonin may help with sleep, and why most benefits in this category are limited to people with a deficiency.
Updated October 4, 2026 — evidence includes the Cochrane reviews of ginkgo (2022) and zinc (2016), the 2016 Lipo-Flavonoid trial, a 2026 systematic review of over-the-counter tinnitus treatments, and military noise-exposure trials
This guide is for educational purposes only. It is not medical advice and should not be treated as such. We are not doctors, audiologists, or licensed healthcare professionals. This content is the result of desk research — reading and summarising publicly available published studies, systematic reviews, and clinical guidelines.
Tinnitus can be a symptom of medically serious underlying conditions: acoustic neuroma, Ménière's disease, otosclerosis, cardiovascular disease, or medication toxicity. New or worsening tinnitus — particularly if sudden in onset, unilateral, or accompanied by hearing loss, vertigo, or neurological symptoms — requires medical evaluation before any supplement is considered.
This guide covers supplements. It does not cover the evidence-based treatments for tinnitus that do exist: cognitive behavioural therapy (CBT) for tinnitus distress, tinnitus retraining therapy (TRT), sound therapy, and hearing aids for patients with concurrent hearing loss. These interventions have stronger evidence than any supplement reviewed here.
Sudden sensorineural hearing loss (SSHL) is a medical emergency — treatment within 24–72 hours with corticosteroids significantly improves outcomes. If tinnitus is new, sudden, or accompanied by any hearing change, seek same-day medical care. Do not attempt supplement management first.
Lipo-Flavonoid is the best-known tinnitus supplement in the United States, sold in pharmacies by Clarion Brands and now marketed as "Ear Ringing". It is not one of the anonymous online products we usually review: the company, the stores and the label are all real. The product contains a proprietary "Tisina Complex" with vitamin C, several B vitamins (B1, B2, niacinamide, B6, B12 and pantothenic acid) and calcium, and the product page also mentions choline and vitamin D. A 150-count bottle listed at $31.49 on the maker's site in October 2026.
The marketing says it is the "#1 ENT doctor recommended" brand and contains ingredients "clinically shown to help manage ear ringing". The maker's own footnotes give the sources: the recommendation claim rests on an April 2018 survey held by Clarion Brands, and the clinical claim cites a 1962 preliminary report presented at a Mayo Clinic staff meeting on citrus bioflavonoids and B vitamins in a type of hearing loss.
The only modern randomized trial we found tested Lipo-Flavonoid Plus in 40 people with tinnitus over six months (Journal of the American Academy of Audiology, 2016). One group took Lipo-Flavonoid with manganese, the control group Lipo-Flavonoid alone. Twelve dropped out. In the Lipo-Flavonoid-only group, none of the 16 who finished improved on the tinnitus questionnaires; two reported quieter tinnitus and one less annoyance. The authors could not conclude that either product is an effective treatment. The trial had no placebo arm, so it cannot rule out a small effect, but it offers no support for one.
Some ENT doctors suggest Lipo-Flavonoid as a low-risk thing to try, partly because there is so little else to offer for chronic tinnitus. That is not the same as evidence that it works. If you try it, give it a fixed period, track your symptoms, and stop if nothing changes.
No vitamin has been shown to reduce tinnitus in people who are not deficient. The exceptions are about deficiency: vitamin B12 deficiency is common in people over 50, vegans and people taking metformin or acid-reducing drugs, and zinc deficiency was found in about a third of patients in one small trial. If you have tinnitus, ask your doctor to check B12 and zinc before buying a supplement for it.
Magnesium and N-acetylcysteine (NAC) have evidence from military trials for protecting hearing during noise exposure, not for treating tinnitus that already exists. Melatonin may help people whose tinnitus disrupts sleep. Ginkgo, the most common ingredient in tinnitus formulas, has no reliable evidence of benefit.
The most pervasive problem in this supplement category is conflating two entirely different conditions that are routinely marketed as one 'hearing health' target.
Tinnitus is a neurological and perceptual phenomenon — the brain's auditory system generating or amplifying phantom sound (ringing, buzzing, hissing) in the absence of an external source. It is measured with validated tools like the Tinnitus Handicap Inventory (THI) and Visual Analog Scale (VAS). Tinnitus often follows cochlear damage but can persist even in people with normal audiograms. It is primarily a central nervous system phenomenon, not an ear condition.
Hearing loss (sensorineural) is structural — irreversible loss of outer hair cells in the cochlea, measured by pure-tone audiometry as elevated thresholds in decibels. Prevention of noise-induced hearing loss (NIHL) involves protecting those cells before damage occurs. Treatment of established sensorineural hearing loss with supplements has no meaningful clinical evidence base.
A supplement that protects cochlear hair cells from oxidative damage (potentially relevant to NIHL prevention) is making a completely different biological claim to one that reduces tinnitus loudness or distress. Many products market against both conditions simultaneously with a single formula, which should be a red flag — the mechanisms, the populations studied, and the outcome measures are different.
A recurring theme in this category is that the best case for several ingredients is limited to people who are deficient. Small studies found low zinc in about a third of tinnitus patients, low B12 in about half of one group of noise-exposed patients with tinnitus, and a fall in tinnitus scores only in the few patients with low CoQ10. None of these is strong evidence, and a 2016 Cochrane review found no evidence that zinc helps tinnitus in general.
This is mechanistically plausible: if a nutrient matters for the cochlea or the auditory nerve, correcting a deficiency may help. It does not follow that people with normal levels will benefit, and no adequate trial has shown that they do.
This distinction matters enormously for evaluating supplement marketing. When a product cites a study showing zinc reduced tinnitus severity, the question is always: what was the zinc status of the participants? If it was a deficiency-correction trial, the result cannot be generalised to the overall tinnitus population.
If you have chronic tinnitus and want to investigate a nutritional angle, the most useful steps are blood tests for zinc, serum B12 (and ideally methylmalonic acid as a functional marker), and CoQ10 levels — particularly if you take statins, which reduce CoQ10 synthesis. Supplementing without knowing your baseline status is less rational.
The table below covers the most studied ingredients in this category. Evidence tiers reflect the quality and consistency of human clinical trial data. NIHL prevention refers to protection against noise-induced hearing loss — a separate outcome from tinnitus treatment.
| Ingredient | Condition | Evidence Tier | Key Note |
|---|---|---|---|
| Melatonin | Tinnitus distress / sleep | Low | Small studies only. In an open-label study of 24 patients (Megwalu et al. 2006, no placebo group), 3 mg a night for four weeks was followed by better Tinnitus Handicap Inventory and sleep scores, with the biggest sleep gains in the poorest sleepers. Any benefit seems to come through better sleep. A 2026 systematic review of over-the-counter tinnitus treatments found no firm evidence for any of them. Higher doses (10–30 mg) are not better supported. |
| Magnesium | NIHL prevention (prophylactic) | Moderate | Attias et al. 1994 (300 military recruits, placebo-controlled): 167 mg of magnesium aspartate a day during two months of basic training with impulse noise led to fewer and milder permanent hearing threshold shifts than placebo. A 2004 follow-up in 20 men found less temporary threshold shift. This is prevention evidence for people about to be exposed to noise, not treatment for established tinnitus. |
| NAC (N-acetylcysteine) | NIHL prevention (acute) | Low–Moderate | Kopke et al. 2015 (566 U.S. Marines, randomized, placebo-controlled, weapons training): no significant difference in the primary outcome, the rate of hearing threshold shifts; a secondary outcome, shifts in the ear on the trigger-hand side, was lower with NAC (27% vs 35%). Laboratory results are stronger than human ones. The rationale for treating chronic, established tinnitus is weak. |
| Folate / Folic acid | Age-related hearing loss | Moderate (population-specific) | Durga et al. 2007 (728 older adults with raised homocysteine, 3-year RCT, Netherlands): 800 mcg a day of folic acid slowed low-frequency hearing decline (1.0 dB vs 1.7 dB). The Netherlands did not fortify food with folic acid at the time, so the result may not apply where food is fortified, as in the U.S. since 1998. It concerns hearing, not tinnitus. |
| Zinc | Tinnitus | None in general; possible in deficiency | A 2016 Cochrane review found "no evidence" that oral zinc improves tinnitus in adults. The small trial often cited for zinc (Arda et al. 2003, 41 patients, 50 mg a day for two months) found 31% had low zinc levels and that subjective severity fell in 82% of those given zinc, but the clinical improvement was not statistically significant. Correcting a confirmed deficiency is reasonable. Long-term intake above 40 mg a day can cause copper deficiency. |
| Vitamin B12 | Tinnitus | Low (deficiency-specific) | Shemesh et al. 1993 (113 noise-exposed army personnel): 47% of those with tinnitus and noise-induced hearing loss had low B12, more than in the other groups. Some improvement was seen in 12 patients after B12 replacement, without a control group. No adequately powered trial has shown benefit in people with normal B12. Deficiency is common in vegans, adults over 50, and people on metformin or acid-reducing drugs. |
| CoQ10 | Tinnitus | Low | Khan et al. 2007: a 16-week non-randomized pilot study of 20 patients found no overall effect on tinnitus scores; in a subgroup of 7 with low starting CoQ10 levels, scores fell. Statin users have lower CoQ10, but no tinnitus trial has tested that group. |
| Alpha lipoic acid | Cochlear protection | Low | Animal studies (Seidman et al., multiple): strong protection against age-related cochlear mitochondrial damage. Human evidence for tinnitus is limited to small, uncontrolled studies. Often studied in combination formulas, making it impossible to attribute any observed effect to ALA specifically. |
| Ginkgo biloba (EGb 761) | Tinnitus | None — Cochrane null | The 2022 Cochrane review found "uncertainty about the benefits and harms" of ginkgo for tinnitus, with low to very low certainty evidence; earlier versions (2004, 2013) found no convincing benefit over placebo. Rejali et al. 2004 RCT (n=66, 12 weeks): no significant difference in THI scores with EGb 761 vs. placebo. Despite being one of the most common ingredients in tinnitus products, ginkgo has the best-evidenced null result in the category. The EGb 761 extract used in serious trials is not equivalent to generic ginkgo supplements. |
| Vinpocetine | Inner ear blood flow / hearing | Low — avoid | No modern rigorous RCTs for tinnitus. Most evidence is from older, methodologically weak Eastern European trials using intravenous delivery. The FDA issued a warning letter in 2019 questioning its legality as a dietary supplement under DSHEA, as it was originally developed and approved as a pharmaceutical drug in several countries. Has antiplatelet effects and possible reproductive toxicity. The regulatory ambiguity alone is a reason to avoid products containing it. |
Ginkgo biloba is probably the most common single ingredient in tinnitus supplements. It also has the most clearly established null result of any ingredient in this category.
Cochrane has reviewed ginkgo for tinnitus three times. The 2004 and 2013 versions found no convincing evidence that it works better than placebo; the 2022 update, which applied stricter criteria, concluded there is "uncertainty about the benefits and harms" and that the evidence is of low to very low certainty. The Rejali et al. 2004 RCT — specifically designed to test the EGb 761 extract at the dose recommended for tinnitus — found no significant difference in Tinnitus Handicap Inventory scores over 12 weeks.
Ginkgo does show some signal in a specific subpopulation: elderly patients with dementia-associated tinnitus, neuropsychiatric symptoms, or anxiety-driven tinnitus distress. This is a different population from the general tinnitus patient, and the effect in that subpopulation is modest and secondary to the primary cognitive/neuropsychiatric outcomes being measured.
The persistence of ginkgo in tinnitus formulas despite this evidence is a marketing legacy — earlier smaller trials showed positive results, driving the ingredient's popularity before rigorous replication reversed the finding. Any product that leads with ginkgo as its primary active ingredient is built around a null result.
EGb 761 (standardised to 24% flavone glycosides / 6% terpene lactones) is the only preparation used in serious clinical trials. Generic ginkgo extract products are not pharmacologically equivalent. Even so, the best trials using EGb 761 specifically for tinnitus fail to show benefit. The extract standard is necessary but not sufficient.
Where to Find Them
FAQ
The evidence says probably not. The only modern randomized trial, in 40 people over six months, found no improvement on tinnitus questionnaires in those taking Lipo-Flavonoid, and the authors could not conclude it is effective. The maker's "clinically shown" claim cites a preliminary report from 1962.
The "#1 ENT doctor recommended" claim comes from a 2018 survey held by the maker, Clarion Brands. Some ENT doctors suggest it as a low-risk option because few treatments exist for chronic tinnitus, not because trials show it works.
None has been shown to reduce tinnitus in people who are not deficient. If a blood test shows low vitamin B12 or zinc, correcting it is reasonable and may help some people. Melatonin may help with tinnitus-related sleep problems.
A 2016 Cochrane review found no evidence that oral zinc improves tinnitus in adults. It may be worth correcting a confirmed zinc deficiency, but long-term doses above 40 mg a day can cause copper deficiency.
There is no reliable evidence that it does. The 2022 Cochrane review found the benefits and harms uncertain, and a dedicated 2004 trial found no difference from placebo. Ginkgo can increase bleeding risk with blood thinners.
Hearing aids for people with hearing loss, sound therapy, and cognitive behavioral therapy for tinnitus distress have better evidence than any supplement. See an audiologist or ENT doctor, and get urgent care for sudden hearing loss or tinnitus in one ear.
Products We've Reviewed
Sold for hearing, but its label lists the same 22 ingredients in the same 200 mg blend, in the same order, as Sugar Defender, a blood sugar supplement. Only chromium has a stated dose (0.7 mcg). Refund pages give 60 and 90 days.
Read full reviewPrints every dose, including 300 mg ginkgo, and offers a real 365-day refund. But ginkgo did no better than placebo in the largest tinnitus trial, and the sales letter claims Harvard and Zurich scientists "prove" a 5-second fix.
Read full reviewZinc and B vitamins plus 12 herbs in an 802 mg blend with no individual doses; none has tinnitus evidence. The label is marketed for memory and mood. BBB rating D with 37 complaints; Trustpilot 86% one star.
Read full reviewFive calming herbs totalling 450 mg, the same as Nerve Fresh at half the dose, with no neuropathy trials. The seller is rated F by the BBB, and buyers describe refunds offered at 20 to 70%.
Read full reviewFive herbs mostly studied for anxiety and sleep, with no neuropathy trials. The site's disclaimer says "Dr. James Haleford" is a pen name played by a paid actor. (An earlier version of this guide wrongly linked it to a CNN deepfake report.)
Read full reviewBottom Line
The tinnitus supplement category has a foundational honesty problem: its most common ingredient, ginkgo biloba, has no reliable evidence of benefit, and the best-known brand, Lipo-Flavonoid, found no benefit in its only modern trial. No supplement has been shown to reduce tinnitus loudness or distress in adults with chronic tinnitus. Melatonin may help people whose tinnitus disrupts sleep, based on small studies. Zinc, B12 and CoQ10 may matter only for people who are deficient, which a blood test can show. Magnesium and NAC are studied for preventing noise damage, not for treating tinnitus. The most useful steps for chronic tinnitus are a hearing test, checks for B12 and zinc deficiency, and the treatments with real evidence: hearing aids where there is hearing loss, sound therapy and cognitive behavioral therapy.
